Reach Us +1-218-451-2974


The Diabetic Effects In Alzheimer Disease: The Role Of Insulin And ? Amyloid Peptide | 12478
ISSN: 2161-0460

Journal of Alzheimers Disease & Parkinsonism
Open Access

Like us on:

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
Google Scholar citation report
Citations : 2275

Journal of Alzheimers Disease & Parkinsonism received 2275 citations as per Google Scholar report

Journal of Alzheimers Disease & Parkinsonism peer review process verified at publons
Indexed In
  • Index Copernicus
  • Google Scholar
  • Sherpa Romeo
  • Open J Gate
  • Genamics JournalSeek
  • Academic Keys
  • JournalTOCs
  • China National Knowledge Infrastructure (CNKI)
  • Electronic Journals Library
  • RefSeek
  • Hamdard University
  • OCLC- WorldCat
  • SWB online catalog
  • Virtual Library of Biology (vifabio)
  • Publons
  • Geneva Foundation for Medical Education and Research
  • Euro Pub
Share This Page

The diabetic effects in Alzheimer disease: The role of insulin and ? amyloid peptide

International Conference on Psychology, Autism and Alzheimers Disease

Maria Elisa de Oliveira Lanna

ScientificTracks Abstracts: J Alzheimers Dis Parkinsonism

DOI: 10.4172/2161-0460.S1.002

Insulin resistance, hyperinsulinemia, glucose intolerance and products related to insulin metabolism can affect the amyloid cascade and collaborate in precipitation of the Alzheimer dementia picture or aggravate it, in early or old age, regardless of development of type 2 diabetes. The changes described in pathological studies and molecular research, classify two types of mechanism involved with cognitive impairment in these cases: one related to cerebrovascular events due the action of vascular risk factors, and the other controversial, non-cerebrovascular, from the interaction of insulin with the A? in the entorhinal cortex and hippocampus, as well as its direct action modulating NMDA receptors and neurotransmitters as acetylcholine and norepinephrine, not directly related to the glucose modulation. Using the literature review, and clinical observation of cases, we emphasize the role of insulin in the central nervous system and its participation in amyloidogenesis process in the evolution of Alzheimer disease. We bring into discussion the main mechanisms contributing to chronic peripheral hyperinsulinemia, which determines the sensitizing of insulin receptors in the blood-brain barrier (with insulin receptors down regulation) and decreased insulin uptake, causing a state of central hipoinsulinism, triggering interference mainly in the process of the A? regulation and inflammation, of the A? degradation transported to periphery and decreased of the A? clearance, among others, increasing synaptic toxicity, implying in clinical and anatomic changes in favor of the Alzheimer dementia.